One of the most well-established genetic risk factors for MS is the presence of a specific major histocompatibility complex (MHC), the HLA-DR15 haplotype19, which interacts with EBV infection to confer a threefold or higher risk of developing MS20. The gene discussed is HLA-C; the disease is myeloid sarcoma.